Drug-eluting stents for drug-eluting stent restenosis: stick with the old or switch to a new one?
Coron Artery Dis
2014
25
8
633-635
Impact of inhospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention.
Am Heart J
2014
168
6
862-8.e1
Fibrinolysis for patients with intermediate-risk pulmonary embolism.
N Engl J Med
2014
370
15
1402-11
Sympathetic activity-associated periodic repolarization dynamics predict mortality following myocardial infarction.
J Clin Invest
2014
124
4
1770-80
CarioPulse: EuroPCR 2014: the 25th Official Congress of the European Association of Percutaneous Cardiovascular Interventions.
Eur Heart J
2014
35
39
2699
Induced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing.
Pharmacol Ther
2014
143
2
246-52
Drug-eluting stent trials: too much non-inferiority, too little progress?
Lancet
2014
383
9915
386-8
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
JACC Cardiovasc Interv
2014
7
1
29-36
Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes.
EuroIntervention
2014
10
1
83-9
Sympathetic activity-associated periodic repolarization dynamics predict mortality following myocardial infarction (vol 124, pg 1770, 2014)
J Clin Invest
2014
124
6
2808-2808